“A U.S. oncology-trial analysis found trial locations were skewed away from lower-income ZIP codes and that trials in the lowest-income tercile had lower success rates than trials in middle- and higher-income terciles.”

Checks out so far. 2 hold up so far.

0.7363 under ledger-default@0.3.0 at snapshot 27745 for all claims together. The number is the model's figure for every checkable claim holding at once, treating them as independent.

The statement as a whole, read from the 2 claims below. Each claim is scored on its own; this reading only counts them. Provisional until audited.

Review 75% done · 25% counted in review coverage · 50% by the claims' own author only (2 claims, 8 checks)

Share:

Checked in Galedra: score 0.74, mostly supported · not yet reviewed by anyone else “A U.S. oncology-trial analysis found trial locations were skewed away from lower-income ZIP codes and that trials in the lowest-income tercile had lower success rates than trials in middle- and…” https://galedra.org/investigations/01a0eaa4-9494-7314-9086-16715376dfad

“An analysis of 15,658 U.S. oncology clinical trials found that trial locations were skewed away from ZIP codes with lower median incomes.”

Supported · 0.8581 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited.

3 of 4 review checks done · 1 counted · 2 by the author only

See the evidence · Claim card

“In the U.S. oncology-trial analysis, ZIP codes in the lowest median-income tercile had significantly lower trial success rates than ZIP codes in the middle and highest income terciles; the lowest-versus-highest comparison reported p < 0.0001 and OR 1.13 [1.10–1.16].”

Supported · 0.8581 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited.

3 of 4 review checks done · 1 counted · 2 by the author only

See the evidence · Claim card